Sessions for ISC 2019 Live Streaming

Tuesday, Feb 5

Morning:

  • State-of-the-Science Stroke Nursing Symposium:         7:30 am – 11:00 am 
  • Stroke in the Real World: In Search of the Big Kahuna: Rare Causes of Stroke   8:00 am – 5:30 pm
  • Stroke in the Lab World: Cutting-Edge Topics in Experimental Stroke Research   8:30 am – 5:20 pm

Afternoon:

  • Nursing Symposium: Acute Care: Advances in Clinical Research, Practice and Quality Improvement    12:30 pm - 4:30 pm
  • Stroke in the Real World: In Search of the Big Kahuna: Rare Causes of Stroke/8:00 am – 5:30 pm
  • Stroke in the Lab World: Cutting-Edge Topics in Experimental Stroke Research 8:30 am – 5:20 pm

Wednesday, Feb 6

7:00 am - 8:30 am

  • Plasticity and the Promise of Recovery after Stroke: Novel, Practical and Clinical Considerations
  • Perspectives on Vascular Cognitive Impairment and Dementia
  • Acute Endovascular Treatment Oral Abstracts I

 8:45 am – 10:15 am

  • It’s Not “One Size Fits All”: Emerging Issues in Caregiving
  • Small Vessel Disease: A Big Impact on Aged Society (an AHA/ASA and Japan Stroke Society Joint Symposium)
  • Big Picture on Intracerebral Hemorrhage: Practical Implications and Future Outlook

10:30 am – 12 Noon

  • Opening  
  • Welcome and Introduction of AHA/ASA President
  • AHA Presidential Address
  • ISC Program Chair's Welcome
  • Introduction to the William M Feinberg Award for Excellence in Clinical Stroke Lecture
  • William M Feinberg Award for Excellence in Clinical Stroke Lecture:
  • Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Primary Results
  • Glyceryl Trinitrate for Pre-hospital Ultra-acute Stroke: Main Results From the Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial-2 (RIGHT-2)
  • Dual Antiplatelet Therapy Using Cilostazol for Secondary Stroke Prevention in High-risk Patients: The Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com)

1:30 pm – 2:30 pm

  • I Know the Best Way to Select Patients and Perform Stroke Thrombectomy (Debate) (an AHA/ASA and Stroke Society of Australasia Joint Symposium)
  • Diagnosis of Stroke Etiology Oral Abstracts I
  • Town Hall Forum: Women in Stroke

3:00 pm – 4:00 pm

  • Post-stroke Psychiatric Symptoms
  • CED Talks (Cerebrovascular Education and Discovery)
  • Telestroke Systems in the Endovascular Era: Extending the Extended Window (an AHA/ASA and American Academy of Neurology Joint Symposium)

4:15 pm – 5:15 pm

  • Superwoman Syndrome: Racial/Ethnic Disparities in Stroke
  • What Do I Do with this Aneurysm?
  • Intracerebral Hemorrhage Oral Abstracts II

Thursday, Feb 7

7:00 am - 8:30 am

  • Vulnerable Carotid Plaque Imaging and Management: A New Dawn?
  • Acute Non-endovascular Treatment Oral Abstracts 316 BC
  • In-hospital Treatment Oral Abstracts

8:45 am – 10:15 am

  • Acute Endovascular Treatment Oral Abstracts II
  • Medical Therapy for Symptomatic Carotid Stenosis: Time for Modern Data
  • Optimal Timing for In-hospital Initiation of Secondary Prevention Therapies in Acute Ischemic Stroke (an AHA/ASA and Chinese Stroke Association Joint Symposium

10:30 am – 12 Noon

  • Main Event Thursday 
  • MISTIE 3 Trial Results
  • Main Results of the Enhanced Control of Hypertension and Thrombolysis Stroke Study (enchanted) of the Early Intensive Blood Pressure Control After thrombolysis
  • MISTIE III Surgical Results: Efficiency of Hemorrhage Removal Determines mRS
  • Andexanet Alfa for Treatment of Factor Xa Inhibitor-related Acute Major Bleeding
  • Endovascular Thrombectomy Outcomes in Large Core on CT Are Strongly Associated With Perfusion Core Volume and Time: Implications From Two Large Cohorts for Future Trials

1:30 pm – 2:30 pm

  • Late-Breaking Science Oral Abstracts I
  • Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (iSPOT) Primary Results
  • A Randomized Trial of Intensive versus Standard Blood-Pressure Control in Patients with a History of Stroke:The Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study
  • Effects of a Quality Improvement Intervention on Adherence to Evidence-based Therapies for Acute Ischemic Stroke and Transient Ischemic Attack Patients in Hospitals With Stroke Units - Insights From the BRIDGE Stroke Trial
  • Spenopalatine-ganglion Stimulation for the Treatment of Acute Ischemic Stroke: Pooled Meta-analysis of the Impact 24A and Impact 24B Trials
  • Stroke, Anticoagulants and Antidotes
  • Cerebral Large Artery Disease Oral Abstracts I

3:00 pm – 4:00 pm

  • Late-Breaking Science Oral Abstracts II
  • Treatment of Carotid Stenosis in Asymptomatic, Non-Octogenarian, Standard Risk Patients with Stenting versus Endarterectomy: A Pooled Analysis of the CREST and ACT I Trials
  • Secondary Stroke Prevention by Uniting Community and Chronic Care Model Teams Early to End Disparities: The SUCCEED Trial
  • Newton-2: Randomized, Double-blind, Placebo-controlled Study of Eg-1962 in Adults With Aneurysmal Subarachnoid Hemorrhage
  • Greater Exercise Dose During Stroke Inpatient Rehabilitation Improves Walking Recovery, but the Response is Not Linear
  • Embolic Strokes of Undetermined Source in 2019
  • SAH and Other Neurocritical Management Oral Abstracts

4:15 pm – 5:15 pm

  • Game of Strokes
  • Implementing and Scaling up Interventions in Diverse Settings: Identifying What Works, Where, and How (an AHA/ASA and African Academy of Neurology Joint Symposium)
  • Salt and Sugar Intake with Increased Risk for Stroke and Vascular Health (an AHA/ASA and World Hypertension League Joint Symposium)

Friday, Feb 8

7:00 am - 8:30 am

  • Reperfusion Injury: Fact or Fiction? (Debate)
  • One Size Fits All? Models for Thrombectomy Systems of Care (an AHA/ASA and Pan American Health Organization Joint Symposium)
  • Emergency Care/Systems Oral Abstracts II

8:45 am – 10:15 am

  • Stroke Telehealth: Controversies and Solutions (an AHA/ASA and World Stroke Organization Joint Symposium)
  • NIH Clinical and Applied Research Programs in Vascular Contributions to Cognitive Impairment and Dementia (VCID) (Joint Government Agency Session)
  • Should Endovascular Stroke Therapy for Large Artery Occlusion be Offered to Children? (Debate)

10:30 am – 12:30 pm

  • Closing 
  • Crossfire Debates
  • Thomas Willis Lecture: Molecular Markers and Mechanisms of Stroke
  • Extending the Thrombolytic Time Window to 9 Hours for Acute Ischemic Stroke Using Perfusion Imaging Selection - The Final Result
  • Intracerebral Hemorrhage Deferoxamine (iDEF) Trial: Main Results
  • Telerehabilitation in the Home versus Therapy In-Clinic for Patients With Stroke